Pfizer Inc (NYSE:PFE)
| 37.60 Delayed Data As of May 26 |  -0.23 / -0.61%Today’s Change | 36.17 Today|||52-Week Range 54.93 | -26.62% Year-to-Date |
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 37.83 |
| Today’s open | 38.03 |
| Day’s range | 37.57 - 38.44 |
| Volume | 20,234,632 |
| Average volume (3 months) | 24,003,142 |
| Market cap | $212.3B |
Data as of 4:00pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +41.45% |
| Earnings growth (this year) | -49.31% |
| Earnings growth (next 5 years) | -1.00% |
| Revenue growth (last year) | +23.43% |
| P/E ratio | 7.4 |
| Price/Sales | 2.93 |
| Price/Book | 2.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.09 | +0.09% |
| AZNAstraZeneca | +0.72 | +1.00% |
| ABBVAbbVie | -1.02 | -0.74% |
| NVONovo Nordisk | +0.57 | +0.35% |
Data as of 4:00pm ET, 05/26/2023
Financials
| Next reporting date | August 1, 2023 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $100.3B |
| Annual profit (last year) | $31.4B |
| Net profit margin | 31.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
